Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
erastin (2 trials)
Multiple Myeloma (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Trials (2 total)
Trial APIs (1 total)